Residual β cell function and monogenic variants in long-duration type 1 diabetes patients
Marc Gregory Yu(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Susan Bonner‐Weir(Joslin Diabetes Center), Hillary A. Keenan(Joslin Diabetes Center), Emily A Wolfson(Joslin Diabetes Center), Zhiheng He(University of Southern California), Hetal Shah(Joslin Diabetes Center), Marcus G. Pezzolesi(University of Utah), Scott G. Frodsham(University of Utah), David Pober(Joslin Diabetes Center), Stephanie D’Eon(Joslin Diabetes Center), Liane J. Tinsley(Joslin Diabetes Center)
Cited by 85
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979